Product Description
Overall, the global midline market was valued at $187 million in 2023. This is expected to increase over the forecast period at a CAGR of 5.2% to reach $267 million.
Throughout this medical market research, we analyzed over 12 midline companies across 7 continents and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts. The full report suite on the global market for midlines includes the accelerated Seldinger technique (AST) and modified Seldinger technique (MST) segments. The MST midline is further categorized into power-injectable and non-power-injectable.
DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- Forecasts Until 2030, and Historical Data to 2020
- Market Drivers & Limiters for Each Segment
- Competitive Analysis with Market Shares for Each Segment
- Recent Mergers & Acquisitions
- COVID19 Impact
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios and SWOT for Top Competitors
Global Midline Market Insights
The global population is growing at a yearly rate of about 0.88%, leading to more people being hospitalized. Consequently, a growing number of patients who would have traditionally received PICCs or PIVCs are now being provided with midline catheters instead.
Global Midline Market Share Insights
- Becton Dickinson (BD) offers a wide range of midline products, such as the PowerGlide® line, and holds a significant share of the power-injectable AST midline market. BD covers all midline segments, providing both older non-power-injectable options like Groshong® Midline Catheter and Per-Q-Cath® Midline Catheter, as well as newer options like PowerMidline™, PowerGlide ST™, PowerGlide®, and PowerGlide Pro™.
- Teleflex is the second-largest player in the midline market, offering various midline catheter kits, including the unique Arrowg+ard Blue Advance™ Midline, which has FDA approval and antimicrobial properties, commanding a premium price.
- AngioDynamics entered the midline market in 2015 with BioFlo® Midline Catheters, designed for power-injection and thrombus prevention. Their BioFlo® technology, present in various vascular access devices, contributed to strong sales in 2023, with a premium price of approximately $130 due to its antithrombogenic properties.
Market Segmentation Summary
- AST Midline Market
- MST Midline Market
Global Research Scope Summary
Report Attribute | Details |
---|---|
Regions | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
Base Year | 2023 |
Forecast | 2024-2030 |
Historical Data | 2020-2023 |
Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
Qualitative Coverage | COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.